http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008062476-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e38e494350e9fa38ff3a31f7713a3b39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d1e6ba1285d3992f4024570f5bc1ff5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d5215618c1a61ac5a23cdda85167f3e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6aac582bbc171738d1d36f16b5bda168
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_845a4cc598a237ee95c10b39111ae01e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18
filingDate 2007-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49164402cfb0ff0b382bdf7f5c336275
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2604c182ef8be89b187f823111b8bbf3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b048e815180721ae6bb0c14923f4f24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a411e19f9957bf9ca4beb7363cafdc6
publicationDate 2008-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2008062476-A3
titleOfInvention Pharmaceutical composition comprising rosuvastatin or pharmaceutically accepatble salts thereof
abstract The present invention relates generally to a pharmaceutical compositions comprising an HMG Co-A reductase inhibitor e.g.: rosuvastatin or pharmaceutically acceptable salts thereof and inorganic salt of a monovalent cation.
priorityDate 2006-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0035425-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006006021-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004010980-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007202159-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394949
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446157
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226753552
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282455

Total number of triples: 34.